Jennifer A. Wargo
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Articles (36)
Table S6. Gene set enrichment analysis using the KEGG pathways and Gene Ontology Biological Processes databases. Pathways statistically significant activated or suppressed after twelve months exercise are displayed (BH-adjusted P-value
Year:
2025
Table S2. Number of Patients Experiencing Adverse Events by Maximum Grade consent and initiation of exercise regimen (Pre-Study) and in the exercise and usual care group. List with the number of patients experiencing adverse events. Should a patient experience any adverse event, the patient is counted only at the highest (maximum) grade experienced.
Year:
2025
Immune cell analysis by BMI and sex. A. Immunohistochemistry (IHC) analysis of the MDA cohort stratified by BMI and sex. Line represents median +/- interquartile range; each dot represents a single tumor. B. IHC analysis of the Gide cohort stratified by BMI and sex. Line represents median +/- interquartile range; each dot represents a single tumor.
Year:
2025
Integrated gene set enrichment analysis of subgroups by body mass index BMI. This figure compares gene expression between overweight/obese (OW/OB) and normal (NL) BMI patients with metastatic melanoma across subgroups by sex, cohort, and tissue site. Supplementary Figure 2 presents a dotplot of genes differentially up- or downregulated in OW/OB patients versus NL BMI patients by subgroups. Red indicates upregulation in OW/OB verse NL.
Year:
2025
Figure S5. (A) Gene Set Enrichment Analysis (GSEA) of BIOCARTA IL-6 pathway; (B) Gene set of IL-6-stimulated cell cultures; (C) Gene set in IL-6-deprived cell cultures. GSEA was performed by 1000 permutations. The maximum and minimum sizes for gene sets were 500 and 15, respectively. The y-axis represents the enrichment score (ES) and the x-axis lists the ranked genes by fold change. Vertical black lines on the x-axis represent the genes in gene sets. The green line connects points of ES and genes. ES is the maximum deviation from zero as calculated for each gene going down the ranked list and represents the degree of over-representation of a gene set at the top or the bottom of the ranked gene list. The P-value and ES are labeled at the top of the figure. The peak towards to left of the x-axis suggests a positive enrichment of the target gene set and vice versa.
Year:
2025
Integrated gene set enrichment analysis by body mass index (BMI) with correction for S phase. This figure presents a dotplot of genes differentially up- or downregulated in OW/OB patients versus NL BMI patients. Red indicates upregulation in OW/OB verse NL. The far left column is all patients, and then, an analysis controlling for sex, cohort, and tissue site is shown in the 3 columns to the right.
Year:
2025
Table S3. Number of patients experiencing adverse events. Only those toxicities experienced while on the trial are presented in the table. Toxicities during the pre-study stage of the trial, for example, that were present before participants begin intervention were not included. Should a patient experience an adverse event more than once, the patient is only counted once at the highest grade for that adverse event.
Year:
2025
Table S1. Adverse events (AEs) experience by participants with possible or probable relation to the study intervention. Summary of the adverse events by grade, relationship, and arm. Adverse events were reported by subjects, including AEs that happened between consent and initiation of exercise regimen (Pre-Study) and in the exercise and usual care group.
Year:
2025
Figure S4. Relative change in prostaglandin metabolite levels after twelve months follow-up in usual care and exercise groups (A-C, Wilcoxon signed-rank test; ns, P>0.05; *, P ≤0.05; **, P≤0.01).
Year:
2025
Inverse Simpson alpha diversity scores of the fecal microbiome by BMI in patients with metastatic melanoma stratified by sex. Box plot represents the median bar with the box bounding the IQR and whiskers the most extreme points within 1.5 x IQR. The red dots represent OW/OB patients and the blue dots represent NL patients by BMI. This is a subgroup analysis of Figure 5C.
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Collaborators (107)
Karen Basen-Engquist
The University of Texas MD Anderson Cancer Center
Lawrence N. Kwong
Assistant Professor
The University of Texas MD Anderson Cancer Center
Georgina V. Long
University of Sydney
Richard Yang
Assistant Professor, Molecular Genetic Pathology
The University of Texas MD Anderson Cancer Center
Gabriele Romano
Assistant Professor
Drexel University
Guido Kroemer
-
Lauren Haydu
Assistant Professor of Biostatistics
Mayo Clinic
Gordon Mills
Professor
Oregon Health & Science University
Carrie Daniel
Professor
The University of Texas MD Anderson Cancer Center
Michael A. Davies
-
Valerio Iebba
Assistant Professor
University of Trieste
Didier Hocquet
Full Prof. - Hospital Practitioner
Hôpital Jean Minjoz
Jianjun Gao
Assistant Professor
The University of Texas MD Anderson Cancer Center
olivier adotevi
INSERM UMR 1098 RIGHT
Johannes Fahrmann
Assistant Professor
The University of Texas MD Anderson Cancer Center
matthew ross
Assistant Professor
Baylor College of Medicine
Cheuk Hong Leung
The University of Texas MD Anderson Cancer Center
Mathieu Chevalier
Assistant Professor
INSERM U976, Institut de Recherche Saint-Louis, Université de Paris
Chantale Bernatchez
The University of Texas MD Anderson Cancer Center
Ralph J. DeBerardinis
University of Texas Southwestern Medical Center
Kristi Hoffman
Assistant Professor
Baylor College of Medicine
Markus Maeurer
University of Mainz
Jennifer L. McQuade
The University of Texas MD Anderson Cancer Center
Jun Li
Associate Professor
University of North Carolina at Chapel Hill
Alexander M. Menzies
University of Sydney
Julia Thorn-Seshold
Group Leader
Technische Universität Dresden
Roni Wilke
The University of Texas MD Anderson Cancer Center
Theodore S. Nowicki
University of California
Yisheng LI
Professor
The University of Texas MD Anderson Cancer Center
Anil Sood
Professor
The University of Texas MD Anderson Cancer Center
Sanghoon Lee
Associate Professor
The University of Texas MD Anderson Cancer Center
Greg M. Delgoffe
-
Florencia McAllister
The University of Texas MD Anderson Cancer Center
Amir Jazaeri
Professor
The University of Texas MD Anderson Cancer Center
John Kirkwood
Distinguished Service Professor of Medicine
University of Pittsburgh
Simon Rothenfusser
Professor
Ludwig-Maximilians-Universität München
Andrew Futreal
Chair and Professor
The University of Texas MD Anderson Cancer Center
Susan C. Gilchrist
Professor
University of North Carolina at Chapel Hill
Melinda S. Yates
Associate Professor
University of North Carolina at Chapel Hill
laurence ZITVOGEL
Université Paris-Saclay
Vashisht Yennu Nanda
Associate Professor
The University of Texas MD Anderson Cancer Center
Jeffrey How
Assistant Professor
The University of Texas MD Anderson Cancer Center
Nicola Segata
Group Leader
University of Trento
Genevieve Boland
Chair of Surgery
Medical College of Wisconsin
Junya Fujimoto
Professor and Chair
Hiroshima University Hospital
John Thompson
Clinical Professor
University of Sydney
Samir M. Hanash
The University of Texas MD Anderson Cancer Center
Triantafyllos Stylianopoulos
Associate Professor
-
James P. Allison
Professor and Chair
The University of Texas MD Anderson Cancer Center
Yibo Dai
The University of Texas MD Anderson Cancer Center
Eduardo Vilar
Assistant Professor
The University of Texas MD Anderson Cancer Center
Patrick Lynch
Professor
The University of Texas MD Anderson Cancer Center
Grant Fischer
Assistant Professor of Molecular Genetic Pathology (Tenure Track)
University of North Carolina at Chapel Hill
Shannon Westin
The University of Texas MD Anderson Cancer Center
Meenhard Herlyn
Professor, Director
The Wistar Institute
J. Jack Lee
Professor
The University of Texas MD Anderson Cancer Center
Sebastian Kobold
University Hospital
Jessie Villanueva
Associate Professor
The Wistar Institute
I. Jolanda M. de Vries
Department head
Radboudumc
Gwyn Richardson
Professor
The University of Texas MD Anderson Cancer Center
Elizabeth Burton
The University of Texas MD Anderson Cancer Center
Michael White
Assistant Professor
-
David S. Hong
The University of Texas MD Anderson Cancer Center
Isabella C Glitza Oliva
Professor
The University of Texas MD Anderson Cancer Center
Tara C. Mitchell
-
Aditya Mishra
University of Georgia
Lisa Derosa
Assistant Professor
Université Paris-Saclay
Ryan Sullivan
Harvard University
Christine Spencer
Parker Institute for Cancer Immunotherapy
Manoj Chelvanambi
The University of Texas MD Anderson Cancer Center
Pamela Soliman
Associate Professor
The University of Texas MD Anderson Cancer Center
Cara Haymaker
Associate Professor
The University of Texas MD Anderson Cancer Center
Robert Jenq
Professor
City Of Hope National Medical Center
Dirk Schadendorf
University Hospital Essen
Funda Meric-Bernstam
The University of Texas MD Anderson Cancer Center
Han Liang
The University of Texas MD Anderson Cancer Center
Ana Aparicio
Professor
The University of Texas MD Anderson Cancer Center
Rodabe N. Amaria
Assistant Professor
The University of Texas MD Anderson Cancer Center
Seyed Javad Moghaddam
Professor
The University of Texas MD Anderson Cancer Center
Silvia Formenti
Cornell University
Sumit Subudhi
Assistant Professor
The University of Texas MD Anderson Cancer Center
James Wilmott
Associate Professor
The University of Sydney Library
Minetta Liu
Research Collaborator, Professor
Mayo Clinic
James Costello
Associate Professor
University of Colorado School of Medicine
Ernest Hawk
The University of Texas MD Anderson Cancer Center
Ying Yuan
Professor
The University of Texas MD Anderson Cancer Center
Yitao Tang
The University of Texas MD Anderson Cancer Center
Sophie Caillat-Zucman
Professeur
Université Paris Diderot
yana najjar
University of Pittsburgh
Kai Wucherpfennig
Professor and Department Chair
Dana-Farber Cancer Institute
Alexander Lazar
Professor
The University of Texas MD Anderson Cancer Center
Noam Auslander
Assistant professor
The Wistar Institute
Julie Densmore
Parker Institute for Cancer Immunotherapy
Christine Peterson
Associate Professor
Rice University
Nadim Ajami
Executive Director
The University of Texas MD Anderson Cancer Center
Don L. Gibbons
The University of Texas MD Anderson Cancer Center
Humam Kadara
The University of Texas MD Anderson Cancer Center
Qi Long
Professor
University of Pennsylvania
Timothy Yap
The University of Texas MD Anderson Cancer Center
Richard A. Scolyer
Faculty Member
University of Sydney
Joseph Petrosino
Department Chair
Baylor College of Medicine
Christina Dieli-Conwright
Dana-Farber Cancer Institute
Qian Zhang
The University of Texas MD Anderson Cancer Center
Nagireddy Putluri
Professor (Tenured)
Baylor College of Medicine
Linghua Wang
Executive Director & Head
The University of Texas MD Anderson Cancer Center
David Boruta
Professor
The University of Texas MD Anderson Cancer Center
Weiyi Peng
Director
University of Houston
Make your next move.
Prepare your application
Review drafts before you send them.